Mohan Thanikachalam Email

CEO, President, and Co-Founder . Dynocardia

Current Roles

Employees:
24
Revenue:
$6.5M
About
Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrack™, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events.
Dynocardia Address

Cambridge, MA
United States
Dynocardia Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.